Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial

Anne Boerekamps; A De Weggheleire; GE van den Berk; FN Lauw; MAA Claassen; D Posthouwer; WF Bierman; Sebastiaan Hullegie; Stephanie Popping; David van de Vijver; ASM Dofferhoff; GJ Kootstra; EM Leyten; J Hollander; ME van Kasteren; R Soetekouw; HSM Ammerlaan; J Schinkel; E Florence; JE Arends; Bart Rijnders

doi:10.1016/S2468-1253(18)30414-X

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial

Anne Boerekamps, A De Weggheleire, GE van den Berk, FN Lauw, MAA Claassen, D Posthouwer, WF Bierman, Sebastiaan Hullegie, Stephanie Popping, David van de Vijver, ASM Dofferhoff, GJ Kootstra, EM Leyten, J Hollander, ME van Kasteren, R Soetekouw, HSM Ammerlaan, J Schinkel, E Florence, JE ArendsBart Rijnders

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	269-277
Number of pages	9
Journal	Lancet Gastroenterology & Hepatology
Volume	4
Issue number	4
DOIs	https://doi.org/10.1016/S2468-1253(18)30414-X
Publication status	Published - 2019

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2468-1253(18)30414-X

http://hdl.handle.net/1765/116366

Cite this

Boerekamps, A., De Weggheleire, A., van den Berk, GE., Lauw, FN., Claassen, MAA., Posthouwer, D., Bierman, WF., Hullegie, S., Popping, S., van de Vijver, D., Dofferhoff, ASM., Kootstra, GJ., Leyten, EM., Hollander, J., van Kasteren, ME., Soetekouw, R., Ammerlaan, HSM., Schinkel, J., Florence, E., ... Rijnders, B. (2019). Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. Lancet Gastroenterology & Hepatology, 4(4), 269-277. https://doi.org/10.1016/S2468-1253(18)30414-X

@article{3efc39fe98964d59a996ce4a69f9152d,

title = "Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial",

author = "Anne Boerekamps and {De Weggheleire}, A and {van den Berk}, GE and FN Lauw and MAA Claassen and D Posthouwer and WF Bierman and Sebastiaan Hullegie and Stephanie Popping and {van de Vijver}, David and ASM Dofferhoff and GJ Kootstra and EM Leyten and J Hollander and {van Kasteren}, ME and R Soetekouw and HSM Ammerlaan and J Schinkel and E Florence and JE Arends and Bart Rijnders",

year = "2019",

doi = "10.1016/S2468-1253(18)30414-X",

language = "Undefined/Unknown",

volume = "4",

pages = "269--277",

journal = "Lancet Gastroenterology & Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd.",

number = "4",

}

Boerekamps, A, De Weggheleire, A, van den Berk, GE, Lauw, FN, Claassen, MAA, Posthouwer, D, Bierman, WF, Hullegie, S, Popping, S , van de Vijver, D, Dofferhoff, ASM, Kootstra, GJ, Leyten, EM, Hollander, J, van Kasteren, ME, Soetekouw, R, Ammerlaan, HSM, Schinkel, J, Florence, E, Arends, JE & Rijnders, B 2019, 'Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial', Lancet Gastroenterology & Hepatology, vol. 4, no. 4, pp. 269-277. https://doi.org/10.1016/S2468-1253(18)30414-X

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. / Boerekamps, Anne; De Weggheleire, A; van den Berk, GE et al.
In: Lancet Gastroenterology & Hepatology, Vol. 4, No. 4, 2019, p. 269-277.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial

AU - Boerekamps, Anne

AU - De Weggheleire, A

AU - van den Berk, GE

AU - Lauw, FN

AU - Claassen, MAA

AU - Posthouwer, D

AU - Bierman, WF

AU - Hullegie, Sebastiaan

AU - Popping, Stephanie

AU - van de Vijver, David

AU - Dofferhoff, ASM

AU - Kootstra, GJ

AU - Leyten, EM

AU - Hollander, J

AU - van Kasteren, ME

AU - Soetekouw, R

AU - Ammerlaan, HSM

AU - Schinkel, J

AU - Florence, E

AU - Arends, JE

AU - Rijnders, Bart

PY - 2019

Y1 - 2019

U2 - 10.1016/S2468-1253(18)30414-X

DO - 10.1016/S2468-1253(18)30414-X

M3 - Article

SN - 2468-1253

VL - 4

SP - 269

EP - 277

JO - Lancet Gastroenterology & Hepatology

JF - Lancet Gastroenterology & Hepatology

IS - 4

ER -